Skip to main content
Toggle Menu of ADA WebSites
ADA Websites
Toggle Member Links
Toggle Menu
e-mail Print Share
Estimating salivary carriage of severe acute respiratory syndrome coronavirus 2 in nonsymptomatic people and efficacy of mouthrinse in reducing viral load (November 2021 Article 1)
CE Credit(s):
Member Price:
Retail Price:
Open Tabs

JADA November 2021

Background. Many people infected with severe acute respiratory syndrome coronavirus 2 (SARSCoV- 2) never develop substantial symptoms. With more than 34 million people in the United States already infected and highly transmissible variants rapidly emerging, it is highly probable that post- and presymptomatic people will form an important fraction of those seeking dental care. Salivary carriage rates in these populations are not known. Moreover, although preventing transmission is critical for controlling spread, the efficacy of mouthrinses in reducing oral viral load is poorly studied.

Keywords. Aerosol; dental; saliva; SARS-CoV-2; mouthrinse; povidone-iodine; hydrogen peroxide; saline; chlorhexidine.